A global, member-driven non-profit organization mobilizing life sciences and healthcare. DIA fosters innovation to improve health and well-being worldwide. Professionals from 80 countries continue to engage with DIA through our unparalleled membership network, educational offerings, and professional development opportunities.

Collaborating for Healthcare Innovation – a focus on Sustainability!

18-20 March 2025
Basel, Switzerland

DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.

Join us in the vibrant city of Basel for an unforgettable experience, where the power of collaboration will be on full display to inspire actionable outcomes and mobilise for solutions the life sciences’ community. Witness first-hand the profound impact of united efforts, gain valuable insights from across the drug development lifecycle, and play an active role in shaping the future of the pharmaceutical arena.

DIA Europe 2025

DIA Europe 2024 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2024 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.

Join us in the vibrant city of Brussels for an unforgettable experience, where the power of collaboration will be on full display to inspire actionable outcomes and mobilise for solutions the life sciences’ community. Witness first-hand the profound impact of united efforts, gain valuable insights from across the drug development lifecycle, and play an active role in shaping the future of the pharmaceutical arena.

DIA Europe 2024

Join us for the DIA Medical Information and Communications Conference - the ultimate gathering for medical information professionals! Drawing on a legacy of successful past editions, our conference is packed with insights and inspiration on improving customer experience with pharma/biotech companies across all touchpoints

You will have the opportunity to network with other medical information professionals, sharing learnings and forging valuable connections that can help you advance your career.

Whether you are a seasoned professional or just starting out in the field, the DIA Medical Information and Communications Conference is the must-attend conference of the year!.

Medical Information and Communications Conference

For it's 35th anniversary, DIA Europe is back in Basel, where all thought leaders meet in person to discuss, inspire, and network.

Join us in Basel: March 22-24, 2023

DIA Europe 2023 is designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need for your everyday job. Your participation will accelerate your growth and your organization's performance in the drug development ecosystem.

Gathering innovative thought leaders from the entire life science landscape, DIA always has the aspiration to be ahead of current developments, reflected by 4 new content tracks in 2023:

- Artificial Intelligence and Data Science
- EU Health Policy and Regulatory Strategy
- Medical Devices and Combination Products
- Professional Development

DIA Europe 2023

*A Roadmap for ePI implementation*
Current Status of ePI Implementation and Its Challenges
Identifying the Opportunities and Next Steps
How To Achieve ePI Implementation
 

Pharmacovigilance
To build an international harmonized framework, which facilitates achieving patient safety across counties around the globe.    
To explore how to get the organization to a state where it is able to deal with the regulatory divergence in PV that we currently see.
To identify the next steps, what potential actions, innovations and solutions should be explored?
 

Reliance in Action
Reflections from Session 1 & 2
Tackling New MAs and LCM
Post Conference Action Plan
 

Regulatory Strategy Collaboration
What are the biggest challenges to the development and approval of Innovative Therapies?
How can all stakeholders contribute to these challenges?